Vicente's Endorsements:
That Khiron Science company Fox serves on seems rather interesting. One of our negative drags here (and there are a lot of those unfortuneately) is an investor there and seems to like it. I suspect that's what bought him here. Fleas seems to tag along all breeds.
Anyway, it says something about Vicente's choice of companies. I kinda like that company on a skim. Nothing stands out as scam. It seems pretty expensive, even now, but they have dome some intereesting things. And they have a lot of cash like Kern. Granted, a lot of cash burn like Kern too.
But, they could be ramping up on something big perhaps. They report on Sedar, which is a more reputable exchange than America's equivalent OTC. That's another question I have to remember to ask HLIX. If those plans will come back and why did those plans get quashed to report dually on Sedar.
Some interesting excerpts from their latest 10Q: "As of March 31, 2020 the Company had repurchased 511,500 common shares for a total cost of $212,389. No further shares have been repurchased subsequent to March 31 to the date of this Interim MD&A."
They have a lot more shares than us at this time. Interesting they would buy some back with such a cash burn at this time. And it's not like it makes a dent. Nor does it make much of a dent if they were to buy all that they are approved to buy back over the course of a year.
I also like their financing: "In Q1 2019, the Company completed a bought deal financing, issuing 13,110,000 common shares at a
price of $2.20 per common share for aggregate gross proceeds of $28,842,000. In consideration for their
services, the Company paid the underwriters a cash commission equal to 6% of the gross proceeds and
non-transferable compensation options equal to 6% of the common shares sold. Each compensation option
issued will be exercisable at the issue price of $2.20 to acquire one common share expiring February 28,
2021"
While they are burning through the cash fast, they don't have toxic warrants. Those warrants are exercisable far above today's price. They have 3 segements of revenue. All if it comes from just one source basically. The other is basically a zero. Maybe that's like our Amercanex at this time. And the other cosmetics for all practical purposes.
Very tiny revenue from their cosmetic line as I call it. Seems geared to women. They buy that stuff. Looks gimmicky to me, but I love the branding and the rip-off prices. Voo doo science, promises of youth, and women, are a very good combination for profits! They are deinitely legit.
The only real source of income so far are two large facilities. One very new. And very recent approvals to sell, and so far *at this time* monopolitic licenses as only they have approval AT THIS TIME. They require prescriptions and doctors for medical purposes. That's a good profitable combination. Health Care. Total price gouging. That's good. I bet Vincente Fox had a good influence there.
HLIX enjoys over twice its revenue at this time and much closer to profitability. But Khiron is interesting. And more expenseive than HLIX on a market cap. It's a good little company with some promise for the future. Kinda expensive perhaps, but I think they are sincere. Wouldn't be bad to have a foot in the door there.
